Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2788 of 5804
-
Timing your meals may lower breast cancer risk, study finds
Prevention CompletedThis study will evaluate the implementation and effectiveness of free-living TRE on biological and behavioural breast cancer risk factors.
Phase: NA • Sponsor: University of Toronto • Aim: Prevention
Last updated Jun 27, 2026 07:53 UTC
-
Could a Weight-Loss pill help teens with type 2 diabetes?
Disease control OngoingAs the prevalence of obesity rises in the U.S., so does the incidence of pediatric type 2 diabetes (T2D), which is associated with more aggressive disease progression than in adults. From 2002-2012, the incidence of T2D in youth increased by 7% annually in the U.S. Compared to ad…
Phase: EARLY_PHASE1 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could your own nerves help heal Parkinson's? small trial begins
Disease control OngoingThis is an open-label, non-randomized, single-arm trial design to actively follow participants for 12 months. Ten participants will be enrolled to receive bilateral delivery of Peripheral Nerve Tissue (PNT) to the Substantia Nigra at the time of Deep Brain Stimulation (DBS) surge…
Phase: PHASE1 • Sponsor: Craig van Horne, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Heart surgery patients get faster healing with own blood plasma
Disease control CompletedThe goal of this clinical trial is to learn whether applying autologous platelet-rich plasma (PRP) to the sternal wound during heart surgery improves wound healing and reduces complications after surgery. The study also aims to evaluate whether PRP can reduce hospital-related out…
Phase: NA • Sponsor: Shaheed Zulfiqar Ali Bhutto Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New program aims to help hispanic kids bounce back after brain injury
Symptom relief Recruiting nowTraumatic brain injury (TBI) is a significant problem for U.S. Hispanic children. Compared to non-Hispanic children, Hispanic children have higher long-term disability and lower health related quality of life, even though differences are not present at hospital discharge. Rehabil…
Phase: NA • Sponsor: Seattle Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Could a cancer drug combo slow Alzheimer's?
Symptom relief OngoingThis study is being done to evaluate the safety and feasibility of using Dasatinib and Quercetin together in subjects with Mild Cognitive Impairment (MCI) or Alzheimer's disease.
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
New cancer drug BGB-24714 tested in early trial for solid tumors
Disease control TerminatedThis study aims to understand how safe and well-tolerated a drug called BGB-24714 is when used alone, or in combination with chemotherapy or radiation therapy, for people with advanced or spreading solid tumors. The main objective is to identify the highest tolerable dose or the …
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug combo tested for tough-to-treat cancers
Disease control Recruiting nowPart 1 • To determine the safety and tolerability of TRK-950 in patients with advanced solid tumors Part 2 • To determine the safety and tolerability of TRK-950 in combination with nivolumab(NIVO) in patients with advanced solid tumors eligible for NIVO therapy Part 3 • To d…
Phase: PHASE1, PHASE2 • Sponsor: Toray Industries, Inc • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Scientists map brain activity to unlock movement secrets in Parkinson's
Knowledge-focused OngoingSeveral strategies or contexts help patients with Parkinson's disease to move more quickly or normally, however the brain mechanisms underlying these phenomena are poorly understood. The proposed studies use complimentary brain mapping techniques to understand the brain mechanism…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
RINVOQ tested in Real-World study for back pain disease
Disease control CompletedAxial spondyloarthritis (axSpA), which encompasses radiographic axSpA (r-axSpA, also known as ankylosing spondylitis \[AS\]) is an immune-mediated inflammatory disease primarily affecting the axial skeleton. This study will assess how effective Rinvoq is in treating axSpA. Rinvo…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Twin pregnancy mystery: could vaginal microbes predict early delivery?
Knowledge-focused OngoingThe aim of this study is to try and find links between the microscopic organisms (such as bacteria, yeasts and viruses) in the vagina, and twin pregnancies that deliver too early (preterm birth). Being born earlier than expected (preterm birth) happens in over half of twin pregn…
Sponsor: University of Liverpool • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:22 UTC
-
New drug INCB123667 enters human trials for Hard-to-Treat cancers
Disease control OngoingThis is an open-label, dose-escalation and dose-expansion study to determine the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy of INCB123667 when administered as monotherapy and in combination with anticancer therapies in participants with selected advanced…
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New drug combo shows promise in early brain cancer trial
Disease control CompletedThis study will evaluate the addition of regorafenib to standard of care treatment with TMZ as adjuvant therapy, and in combination with TMZ+RT as concomitant therapy. The standard of care for newly diagnosed GBM (ndGBM) includes surgical resection to the extent that is safely f…
Phase: PHASE1 • Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Pharmacists step in to tame uncontrolled diabetes
Disease control OngoingType 2 diabetes is a chronic disease that can lead to a number of complications if uncontrolled and there is a projected increase of 33% patients living with diabetes over the next 10 years. There can be improvements to modifiable risk factors such as diet and exercise, in additi…
Phase: NA • Sponsor: University of Manitoba • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a simple supplement shrink fibroids and prevent surgery?
Disease control Recruiting nowThe study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6. The patients will be evaluated at baseline and after three months of treatment with placebo or pro…
Phase: NA • Sponsor: Lo.Li.Pharma s.r.l • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Patient's own immune cells plus drug tested against tough melanoma
Disease control OngoingThis phase I/II trial tests the safety and side effects of LN-144 (Lifileucel) and pembrolizumab in treating patients with stage IIIB-D or stage IV melanoma that has spread to nearby tissue or lymph nodes. Biological therapies, such as LN-144 (Lifileucel), use substances made fro…
Phase: PHASE1 • Sponsor: Richard Wu • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Veterans' heart failure study tests simple knee exercise fix
Knowledge-focused Recruiting nowHeart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care System. Exercise intolerance is a common complication experienced by patients with HFpEF, perpetuating physical inactivity a…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a Parkinson's drug protect eyes in diabetes?
Disease control ENROLLING_BY_INVITATIONTo determine if levodopa will slow the appearance of blood vessel changes in the eyes of patients with diabetes. Treatment will be started in patients with diabetes show delays in the electrical activity of the retina when measured non-invasively with a electroretinogram.
Phase: EARLY_PHASE1 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Fatigue in MS might be caused by low antibodies – new study investigates
Knowledge-focused Recruiting nowThe investigators hypothesize that hypogammaglobulinemia (defined as IgG serum concentration \<7.0g/L) is a treatable cause of fatigue in people with MS: The primary objective is to prove the link between hypogammaglobulinemia and fatigue in patients with multiple sclerosis. Th…
Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Can a quick-start opioid treatment keep probationers out of trouble?
Disease control TerminatedThis five-year study will evaluate the effectiveness of the administration of buprenorphine bridge treatment (BBT) to probationers and parolees compared to treatment as usual (TAU), which consists of referral to a community buprenorphine treatment program.
Phase: PHASE3 • Sponsor: Friends Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC